Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02732834 · ClinicalTrials.gov registry record

Clinician-Patient Communication in Lung Cancer Care

A clinical trial of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
294
Enrollment target
7
Study locations

NCT02732834: Active study of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02732834 is a study of Lung Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 294 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (69% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02732834, a study of Lung Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
294 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaire
  • BEHAVIORAL Patient Interview
  • BEHAVIORAL Audio recordings of clinical consultations
  • BEHAVIORAL 2-hour empathic communication skills training

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack (Consent and follow-up only) - Commack
  • Memorial Sloan Kettering Westchester (Consent and follow-up only) - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau (Consent and Follow-Up only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent and follow-up only) - Montvale

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2016-01
Est. Completion 2027-01

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02732834

The ClinicalTrials.gov registry entry for NCT02732834 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (69% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire is the first listed.

NCT02732834 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT02732834 about?

NCT02732834 is a clinical study titled "Clinician-Patient Communication in Lung Cancer Care". The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The cli...

What is the current status of trial NCT02732834?

This trial is currently active not recruiting. The enrollment target is 294 participants. The study started on 2016-01. Estimated completion is 2027-01.

What conditions does trial NCT02732834 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT02732834?

The interventions under investigation include: Questionnaire (BEHAVIORAL), Patient Interview (BEHAVIORAL), Audio recordings of clinical consultations (BEHAVIORAL), 2-hour empathic communication skills training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02732834?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02732834 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.